Paul Frewer
- Pulmonary and Respiratory Medicine top 1%
- Oncology top 1%
- Molecular Biology top 5%
- Cancer Research top 5%
- Surgery top 10%
- Co-authors
- Mireille CantariniMyung‐Ju AhnJames Chih‐Hsin YangWu‐Chou SuSang-We KimPaul A. DickinsonPasi A. JänneSuresh S. Ramalingam
- Topics
- Lung Cancer Treatments and Mutations (16 papers)DNA Repair Mechanisms (6 papers)Lung Cancer Research Studies (5 papers)
- Journals
- New England Journal of MedicineJournal of Clinical OncologyThe Journal of Clinical Endocrinology & Metabolism
- Partner nations
- United KingdomUnited StatesSouth Korea
In The Last Decade
Paul Frewer
37 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Pulmonary and Respiratory Medicine 2.2k
- Oncology 1.7k
- Molecular Biology 1.3k
- Cancer Research 579
- Surgery 442
Countries citing papers authored by Paul Frewer
This map shows the geographic impact of Paul Frewer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Frewer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Frewer more than expected).
Fields of papers citing papers by Paul Frewer
This network shows the impact of papers produced by Paul Frewer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Frewer. The network helps show where Paul Frewer may publish in the future.
Co-authorship network of co-authors of Paul Frewer
This figure shows the co-authorship network connecting the top 25 collaborators of Paul Frewer. A scholar is included among the top collaborators of Paul Frewer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Frewer. Paul Frewer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Osimertinib + Savolitinib to Overcome Acquired MET-Mediated Resistance in Epidermal Growth Factor Receptor–Mutated, MET -Amplified Non–Small Cell Lung Cancer: TATTONbreakdown → | 95 |
| 2 | 1 | |
| 3 | 71 | |
| 4 | Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b studybreakdown → | 295 |
| 5 | 6 | |
| 6 | 115 | |
| 7 | 149 | |
| 8 | 105 | |
| 9 | 15 | |
| 10 | AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancerbreakdown → | 1585 |
| 11 | 40 | |
| 12 | 126 | |
| 13 | 16 | |
| 14 | Treatment of Patients with the Hypereosinophilic Syndrome with Mepolizumabbreakdown → | 403 |
| 15 | 145 | |
| 16 | 52 | |
| 17 | 34 | |
| 18 | 37 | |
| 19 | 1 | |
| 20 | 4 |
About Paul Frewer
Paul Frewer is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology, having authored 38 papers that have together received 3.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (16 papers), DNA Repair Mechanisms (6 papers) and Lung Cancer Research Studies (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.2k citations), Oncology (1.7k citations) and Cancer Research (579 citations). Paul Frewer has collaborated with scholars based in United Kingdom, United States and South Korea. Frequent co-authors include Mireille Cantarini, Myung‐Ju Ahn, James Chih‐Hsin Yang, Wu‐Chou Su, Sang-We Kim, Paul A. Dickinson, Pasi A. Jänne, Suresh S. Ramalingam, Leora Horn and Yuichiro Ohe. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.